We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $22.7B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.19%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$82.7M
2
PEP icon
PepsiCo
PEP
+$76.8M
3
MAR icon
Marriott International
MAR
+$64.8M
4
TSN icon
Tyson Foods
TSN
+$62.8M
5
PARA
Paramount Global Class B
PARA
+$52.9M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Healthcare 14.77%
3 Financials 11.9%
4 Industrials 11.05%
5 Consumer Discretionary 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRE icon
2176
CareTrust REIT
CTRE
$9.22B
– –
-243
Closed -$3K
CTS icon
2177
CTS Corp
CTS
$1.6B
$0 ﹤0.01%
+53
New +$1K
CUBE icon
2178
CubeSmart
CUBE
$8.76B
$0 ﹤0.01%
3
-154
-98% -$4.41K
CVEO icon
2179
Civeo
CVEO
$351M
– –
-18
Closed –
CVI icon
2180
CVR Energy
CVI
$4.8B
$0 ﹤0.01%
41
– –
CVR icon
2181
Chicago Rivet & Machine Co
CVR
$9.66M
– –
-500
Closed -$13K
CYD icon
2182
China Yuchai International
CYD
$1.4B
$0 ﹤0.01%
113
– –
CYTK icon
2183
Cytokinetics
CYTK
$10.3B
$0 ﹤0.01%
+88
New +$919
DHT icon
2184
DHT Holdings
DHT
$3.42B
– –
-7,000
Closed -$35K
EDC icon
2185
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$192M
– –
-500
Closed -$25K
EFC
2186
Ellington Financial
EFC
$1.71B
$0 ﹤0.01%
64
– –
ENTA icon
2187
Enanta Pharmaceuticals
ENTA
$386M
– –
-1,000
Closed -$22K
ERIE icon
2188
Erie Indemnity
ERIE
$12.7B
– –
-20
Closed -$1K
ESPR
2189
DELISTED
Esperion Therapeutics
ESPR
– –
-500
Closed -$4K
EXAS
2190
DELISTED
Exact Sciences
EXAS
$0 ﹤0.01%
+45
New +$793
FFIC
2191
DELISTED
Flushing Financial
FFIC
– –
-46
Closed –
FIVE icon
2192
Five Below
FIVE
$13.6B
– –
-152
Closed -$7K
FIX icon
2193
Comfort Systems
FIX
$56.8B
– –
-16,187
Closed -$527K
FOR icon
2194
Forestar Group
FOR
$1.37B
$0 ﹤0.01%
+78
New +$942
FOSL icon
2195
Fossil Group
FOSL
$287M
$0 ﹤0.01%
24
– –
FRO icon
2196
Frontline
FRO
$10.5B
$0 ﹤0.01%
1
-31
-97% -$240
FRST icon
2197
Primis Financial Corp
FRST
$396M
– –
-276
Closed -$3K
FXF icon
2198
Invesco CurrencyShares Swiss Franc Trust
FXF
$386M
– –
-1,390
Closed -$136K
GAIN icon
2199
Gladstone Investment Corp
GAIN
$642M
$0 ﹤0.01%
147
– –
GALT icon
2200
Galectin Therapeutics
GALT
$408M
– –
-8,063
Closed -$11K
86 87
88
89 90

Similar funds

EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.7B AUM 32.92% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $22.5B AUM 50.37% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $22.3B AUM 36.19% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.